Literature DB >> 17958750

Factor VIII-specific memory B cells in patients with hemophilia A.

P M W van Helden, P H P Kaijen, K Fijnvandraat, H M van den Berg, J Voorberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17958750     DOI： 10.1111/j.1538-7836.2007.02736.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

1.  HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.

Authors:  R A Ettinger; E A James; W W Kwok; A R Thompson; K P Pratt
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

Review 2.  Genomics of bleeding disorders.

Authors:  A C Goodeve; A Pavlova; J Oldenburg
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

3.  Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.

Authors:  Chao Lien Liu; Meghan J Lyle; Simon C Shin; Carol H Miao
Journal:  Cell Immunol       Date:  2016-01-18       Impact factor: 4.868

4.  Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.

Authors:  Seema R Patel; Taran S Lundgren; Wallace Hunter Baldwin; Courtney Cox; Ernest T Parker; John F Healey; Ryan P Jajosky; Patricia E Zerra; Cassandra D Josephson; Christopher B Doering; Sean R Stowell; Shannon L Meeks
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

5.  Concurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodies.

Authors:  Elizabeth M Bradshaw; Sally C Kent; Vinay Tripuraneni; Tihamer Orban; Hidde L Ploegh; David A Hafler; J Christopher Love
Journal:  Clin Immunol       Date:  2008-10       Impact factor: 3.969

6.  Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents.

Authors:  Brian Boylan; Glenn P Niemeyer; Bonnie Werner; Connie H Miller
Journal:  Haemophilia       Date:  2020-11-20       Impact factor: 4.263

7.  Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells.

Authors:  Alessandra De Paula Pohl; Shivaprasad H Venkatesha; Ai-Hong Zhang; David W Scott
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.